IceCure Medical Operating Cash Flow Per Share 2020-2024 | ICCM
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.064B | $0.003B |
IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel. |